Augmentation of natriuretic peptides (NPs) (especially ANP and BNP) proved many beneficial and ameliorative effects in many cardiovascular diseases, owing to its antioxidant, anti-inflammatory properties, as well as antifibrotic impact18; however, its potential mechanism in prevention of lung injury remains elusive. This evidence concerns the gene NPPA and cardiovascular disorder.